Stem cell-based therapies are thriving. In fact, pharmaceutical companies are increasingly
investing in stem cell technology to develop innovative and potentially valuable new
treatments for severe human diseases, including cancer and neurological disorders, such as
multiple sclerosis, Alzheimer´s and Parkinson´s disease, mood disorders, brain tumors and
even stroke. Moreover, although seminal advances have occurred in understanding stem
cell biology, further work is still needed to bridge the current gap between stem cell
technologies and effective treatments for brain-related disorders. Stimulating the scientific
interest in the topic will certainly accelerate and improve the successful transfer of stem cellbased
discoveries from the bench to the bedside.